公告称，纯利减少主要由于整体收益下降。 智通财经APP讯，HYPEBEAST(00150)发布截至2025年9月30日止6个月的中期业绩，该集团取得收益 2.79亿港元，同比减少22.54%;期内溢利599万港元，同比减少70.4%;每股盈利0.29港仙，拟派发中期股 息每股0.0018港元及特别股息每股0.0029港元。 ...

公告称，收益减少乃主要由于合约金额相对较高的若干项目已于上一期间基本完成;及本期间贡献收益 的项目的合约金额较低。 VICON HOLDINGS(03878)发布截至2025年9月30日止6个月中期业绩，该集团取得收益1.19亿港元，同 比减少28.21%;公司拥有人应占溢利556.6万港元，同比减少13.3%;每股基本盈利1.16港仙。 ...

思博系统(08319)发布截至2025年9月30日止六个月业绩，收益4.76亿港元，同比增长8.9%;公司拥有人应 占溢利506.7万港元，同比下降23.4%;每股基本盈利0.63港仙。 期内收益同比增加，乃主要由于报告期间客户需求转趋强劲。尽管市场环境充满挑战，集团仍成功实现 收益增长，反映出集团具备有效回应客户需求及维持业务发展势头的能力。 ...

消息面上，维他奶国际今日午间公布截至2025年9月30日止6个月中期业绩，收入32.27亿港元，同比减 少6%；毛利16.48亿港元，同比减少7%；公司股权持有人应占溢利1.72亿港元，同比增长1%；每股基本 盈利16.2港仙，中期股息每股4港仙，同比持平。 维他奶国际(00345)午后跌超2%，截至发稿，跌1.92%，报6.65港元，成交额3379.55万港元。 公告称，收入减少6%，主要由于中国内地业务受市况疲弱影响，表现面临挑战。毛利率轻微下跌至 51.1%，主要由于贸易推广开支增加及中国内地产品售价下降，惟部分升幅被原材料成本下降及生产营 运效率提升所抵销。 ...

美建集团(00335)公布截至2025年9月30日止6个月中期业绩，收益4210.5万港元，同比减少14.85%;公司 拥有人应占溢利2552万港元，同比减少8.83%;每股基本溢利0.95港仙。 ...

公告称，收益减少主要归因于完成维修项目。 广骏集团控股(08516)发布截至2025年9月30日止6个月的中期业绩，该公司取得收益880.8万港元，同比 减少53.9%;本公司拥有人应占期内亏损约194.2万港元，同比盈转亏;每股亏损11.18港仙。 ...

智通财经APP讯，君百延集团(08372)公布截至2025年9月30日止六个月的中期业绩，收益5249.2万港 元，同比增长25.92%;公司权益股东应占溢利404.5万港元，同比增长17.62%;每股盈利0.51港仙。 ...

Core Insights - Target Corporation reported weak performance in Q3 of fiscal year 2025, leading to a downward revision of its earnings forecast for the fiscal year [2] Financial Performance - Q3 net sales revenue was $25.27 billion, a year-on-year decline of 1.5%, falling short of market expectations of $25.32 billion [2] - Net profit for the same period was $689 million, down 19.3% year-on-year [2] - Gross margin for Q3 was 28.2%, slightly lower than 28.3% in the same period last year [2] - Comparable sales revenue decreased by 2.7%, marking the third consecutive quarter of decline, compared to a 0.3% increase in the same period last year [2] Future Outlook - The company maintains a forecast for low single-digit sales revenue decline in Q4 of the fiscal year [2] - Adjusted earnings per share guidance for the fiscal year was revised down from $7 to $9 to a new range of $7 to $8 [2] Consumer Behavior - Target's Chief Business Officer noted that consumers remain budget-conscious, particularly in food, essentials, and beauty products [3] - The suspension of the Supplemental Nutrition Assistance Program (SNAP) benefits during the federal government shutdown posed challenges to Q3 performance [3]

Core Points - The company reported a revenue of HKD 178 million for the fiscal year ending March 31, 2025, representing a year-on-year decrease of 3.55% [1] - The annual loss attributable to the company's owners was HKD 97.838 million, which is an increase of 205.67% compared to the previous year [1] - The basic loss per share was HKD 0.079 [1]

Core Insights - Medtronic (MDT.US) shares rose 4% in pre-market trading, reaching $100.14 [1] - For Q2 of fiscal year 2026, Medtronic reported a non-GAAP EPS of $1.36, up from $1.26 a year ago, exceeding analyst expectations of $1.31 [1] - The quarterly net sales for the period ending October 24 were $8.96 billion, compared to $8.4 billion in the same quarter last year, surpassing the expected $8.87 billion [1] - Medtronic raised its fiscal year 2026 non-GAAP EPS guidance to a range of $5.62 to $5.66, up from the previous guidance of $5.60 to $5.66, aligning with analyst expectations of $5.62 [1] - The new earnings guidance includes an estimated impact of approximately $185 million from potential tariffs [1] - The revenue growth forecast for fiscal year 2026 was increased from 5% to 5.5% [1]